Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wan-Teck Darren Lim, National Cancer Centre, Singapore
ClinicalTrials.gov Identifier:
NCT00702182
First received: June 19, 2008
Last updated: October 17, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)